Synthesis of new carolacton derivatives and their activity against biofilms of oral bacteria by Stumpp, Nico et al.
Organic &
Biomolecular Chemistry
PAPER
Cite this: Org. Biomol. Chem., 2015,
13, 5765
Received 7th March 2015,
Accepted 13th April 2015
DOI: 10.1039/c5ob00460h
www.rsc.org/obc
Synthesis of new carolacton derivatives and
their activity against bioﬁlms of oral bacteria†
N. Stumpp,‡a P. Premnath,‡b T. Schmidt,c J. Ammermann,c G. Dräger,c M. Reck,b
R. Jansen,d M. Stiesch,*a I. Wagner-Döbler*b and A. Kirschning*c
Carolacton, a secondary metabolite isolated from the extracts of Sorangium cellulosum, causes mem-
brane damage and cell death in bioﬁlms of the caries- and endocarditis-associated bacterium Strepto-
coccus mutans. Here, we report the total synthesis of several derivatives of carolacton. All new structural
modiﬁcations introduced abolished its biological activity, including subtle ones, such as inversion of
conﬁguration at C9. However, a bicyclic bislactone derivative as well as the methyl ester of carolacton
resulted in compounds with prodrug properties. Their inhibitory activity on S. mutans was proven to be
based on enzymatic hydrolysis by S. mutans which provided native carolacton resulting in bioﬁlm damage
in vivo. Moreover, we demonstrate that carolacton acts also on S. gordonii, S. oralis and the periodontitis
pathogen Aggregatibacter actinomycetemcomitans, causing elongated cells and growth inhibition.
Introduction
Biofilm-associated infections are a significant problem in
medical treatment.1,2 These bacterial communities evade host
defenses and are inherently resistant to antimicrobial agents –
whether they grow on natural surfaces like teeth or on syn-
thetic surfaces like medical devices and implants. Bacteria in
biofilms can be up to a several hundred fold more resistant to
antibiotics than planktonic bacteria.3–5 Moreover, there is a
great need for new therapeutic strategies, as antibiotic resist-
ance has greatly increased. Thus, natural products with novel
modes of action are a promising alternative and a necessity to
existing antibiotics.
The ongoing exploration of the human microbiome has
identified the oral cavity as one of the most diversely popu-
lated habitats in the human body.6 About 700 species have
already been identified in this bacterial community7 and many
of them have never been cultivated until now. Bacteria usually
colonize the oral cavity by forming multispecies biofilms
(“plaque”), attached to accessible surfaces. Streptococcal
species such as Streptococcus gordonii and S. oralis play an inte-
gral role in this process. As early colonizers, they provide
attachment sites for mid and late colonizers, thus essentially
influencing the subsequent stages of oral biofilm formation.8
In health, the host and its bacterial commensals coexist
symbiotically.9–11 Environmental perturbations can disturb this
homeostasis and, as a consequence, pathogenic biofilms can
evolve. These cause a multitude of inflammatory processes in
the oral cavity, including tooth decay and periodontal diseases,
the most prevalent infections in the industrialized world.12
Dental caries is characterized by a shift in the microbial
community towards acid tolerant and aciduric bacteria. These
communities are dominated by gram-positive streptococci
such as S. mutans.13,14 Due to the accumulation of acidic
metabolites on the teeth surfaces, enamel demineralization
is significantly increased, finally leading to tooth decay. The
most prevalent biofilm-related periodontal diseases are gingi-
vitis and periodontitis. When more bacteria become attached,
the gum may respond by becoming inflamed.15 This process is
known as gingivitis. If untreated, bacterial colonization of the
periodontal pockets can develop into periodontitis, a severe
inflammation of the teeth supporting tissues.16 Concurrently,
gram-negative pathogens, such as Aggregatibacter actinomyce-
temcomitans, are enriched within the microbial community.17
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Recently, we discovered and isolated carolacton 1 (Fig. 1)
from the extracts of Sorangium cellulosum strain So ce96.18
Screening revealed unique biological properties of carolacton
1: at nanomolar concentrations it severely reduces the
number of viable cells in biofilms.19,20 In particular, biofilms
containing the caries- and endocarditis-associated bacterium
S. mutans are sensitive to this compound.19,21,22
Our first report on carolacton 1 as well as its first total syn-
thesis23 covered and proved its structure including the assign-
ment of all stereogenic centers. Carolacton 1 features a
polyketide-type backbone which forms a 12-membered macro-
lactone with a 1,2-diol moiety with trans orientation in the
open-chain conformation. Only recently, a second total syn-
thesis and the preparation of derivatives were disclosed by the
group of Phillips.24 Both studies paved the way for the prepa-
ration of analogues. In this report, we disclose a detailed study
of the inhibitory eﬀect of carolacton 1 and several carolacton
derivatives 2–7 on biofilms comprised of the oral species
S. mutans, S. gordonii, S. oralis or A. actinomycetemcomitans. We
prepared derivatives 2–7 either by semi- or by total synthesis in
order to initiate structure–activity-relationship (SAR) studies.
These derivatives diﬀer structurally at several positions from
the parent compound carolacton 1. In derivative 3 the stereo-
genic center at C9 is inverted, while derivatives 2 and 4–7 rep-
resent esters or lactones at C1. We included the methylester 5
which had been studied previously.21 In derivative 6 the posi-
tion 17 is oxidized to the keto group, while the main new struc-
tural feature in δ-lactone 4 is the (R)-configured carbinol at C5
instead of the keto group. Derivative 2 is ring-enlarged with
respect to the macrolactone to a ring size of 14 atoms (ester via
C7 instead of C9) along with the presence of a t-butyl ester.
Finally, derivative 7 is the result of carolacton macrocyclization
between the carboxylate at C1 and the carbinol at C18.
In this report we describe the synthesis of these carolacton
derivatives and show for the first time the eﬀect of carolacton
on biofilms of the early colonizers of dental plaque, S. gordonii
and S. oralis, as well as on the periodontopathogen A. actino-
mycetemcomitans. Moreover, the carolacton analogues enabled
us to study the functional importance of various stereogenic
centers of carolacton.
Results and discussion
Synthesis of carolacton derivatives
Carolacton derivatives 5 and 6 were obtained by semisynthetic
modification of carolacton 1 through (a) methylation with
diazomethane (to yield methyl ester 5) followed by (b) TEMPO-
mediated oxidation which provided ketone 6. The synthesis of
carolacton derivatives 2–4 started from the advanced inter-
mediates 11a and 11b, respectively, of our published total syn-
thesis (Scheme 1).25 These two C9-epimers are formed from
Fig. 1 Carolacton 1 and carolacton derivatives 2–7 studied in this work.
Scheme 1 Last steps towards seco acids 13a and 13b, their macrocycli-
zation by the Mitsunobu reaction and synthesis of carolacton derivative
2. Reagents and conditions: a. i. (R)-10, CrCl2, proton sponge, MeCN,
2 h, rt; ii. 8, 9, NiCl2(dppp), MeCN, o/n, rt (96% for two steps; 11a : 11b =
4.7 : 1); b. Dess–Martin periodinane, CH2Cl2, NaHCO3, 0 °C to rt, 2.5 h
(70%); c. NaBH4, CeCl3·7H2O, CH2Cl2, −50 to −30 °C, 2 h (95%; 11a : 11b
= 1 : 10); d. LiOH (1 M), THF, H2O, rt, 13 h (quant.); e. PPh3, DIAD, THF,
0 °C to rt, 5 h (76%; 14 : 15 = 1 : 1); f. PPh3, DIAD, THF, 0 °C to rt, 5 h
(87%; 14 : 15 = 1 : 3); g. DDQ, CH2Cl2, pH = 7 phosphate buﬀer, 0 °C to
rt, 4 h (95%); h. Dess–Martin periodinane, CH2Cl2, NaHCO3, rt, 24 h
(62%); i. PPTS, i-PrOH/H2O 3 : 1, 22 h, 60 °C (97%); (dppp = 1,3-bis-
(diphenylphosphino)propane, DIAD = diisopropyl azodicarboxylate,
DDQ = 2,3-dichloro-5,6-dicyanobenzoquinone, PPTS = pyridinium-p-
toluenesulfonic acid).
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aldehyde 8 and vinyl iodide 9 by an asymmetric Nozaki–
Hiyama–Kishi reaction utilizing ligand 1026 in excellent yield
and with good diastereocontrol (dr 9-(R)-11a : 9-(S)-11b =
4.7 : 1). To preferentially obtain the unnatural 9(S)-epimer 11b,
the diastereomeric mixture 11a,b was first oxidized followed by
Luche-reduction of ketone 12. Selective hydrolysis of the
methyl ester provided the seco acids 13a and 13b, respectively.
These were separately subjected to Mitsunobu macrolactoniza-
tion conditions. Remarkably, in both cases the same two
macrolactones were formed. Epimer 13a generated the
expected 9-(S)-macrolactone 14 through an SN2-process as well
as the ring enlarged macrocycle 15 in a 1 : 1 ratio through a
SN2′-process.
In the case of the other epimer 13b both macrolactones 14
and 15 were formed in excellent yield, but in a 1 : 3 ratio in
favour of the SN2′ product 15. Structural analysis of 14 was
based on HSQC and HMBC NMR spectroscopy and on the
comparison with NMR data collected for the 9-epi derivative of
14 which is an intermediate in our total synthesis of carolacton
1. For example, compound 14 shows significant changes in
chemical shifts (δ) for 7-H and 9-H compared to its 9-epimer.
The HMBC spectrum of 14 shows a crosspeak of C19 with 9-H
leading to the conclusion that the lactone ring is formed via
C9. In case of macrolactone 15 the HMBC spectrum revealed
the rearranged 14-membered ring due to a crosspeak of C19
with 7-H. The (R)-configuration at C7 was deduced in the final
derivative 2 by comparing NOE data with molecular modeling
data of 2 and its C7-epimer (see ESI†). Observed NOE contacts
across the macrolactone ring between 17-H/23-Me as well as
15-H/23-Me correlated to distances below 3 Å for the energy
minimized conformation of 2 and to distances above 4 Å for
its C7-epimer.
The diﬀerent behaviour of epimeric allyl alcohols 13a and
13b in macrocyclizations under Mitsunobu conditions is sur-
prising. While 13a behaves in the expected manner, if one
assumes activation of the carbinol moiety – the SN2 step yield-
ing lactone 14 proceeds with inversion of configuration and
the SN2′ step furnishing lactone 15 with retention of configur-
ation, the rationale for the formation of cyclization products
14 and 15 obtained from allyl alcohol 13b is less clear. We
assume that 14 is generated with retention of configuration
from 13b after activation of the carboxylic acid instead of the
alcohol. Unlike in the case discussed above, the SN2′ reaction
proceeds with formal inversion of configuration. It has to be
noted that there is precedence in SN2′ reactions for both
stereochemical scenarios. A thorough computational modeling
analysis on the precursor seco acids and possible transitions
states may shed light onto this unusual outcome of the
Mitsunobu macrocyclizations.
A short sequence that relates to the endgame of carolacton
synthesis leads to macrolactone 2. It starts with the oxidative
removal of the PMB group in lactone 15, followed by Dess–
Martin oxidation of the carbinol at C5 and final removal of
acetonide protection at C17/C18.
The synthesis of 9-epi carolacton 3 utilized macrolactone 14
which was transformed into carboxylic acid 16 in two steps.
First the t-butyl ester was hydrolyzed using a mild trans-esteri-
fication protocol with TESOTf (Scheme 2).27 Next the PMB
group was removed to provide carbinol 16 in low yield, as
several side reactions occurred. One of the undesired products
formed during PMB-deprotection was the unusual bislactone
17 which was isolated in 13% yield starting from 14. Here,
undesired δ-lactone formation had occurred as well as a
rearrangement of the acetonide moiety at C17/C18. Evidence
for the rearrangement to a 1,3-acetonide was collected from
the chemical shift of 112 ppm in the 13C-NMR spectrum com-
bined with a missing proton correlation in the HSQC-spectrum
for C18 as well as an unusual high field chemical shift of
114 ppm for the quaternary acetonide carbon.
In fact, during the total synthesis of carolacton (1) we had
observed that crude 18 can undergo spontaneous δ-lactoniza-
tion between the alcohol at C5 and the carboxylic acid at C1,
e.g. during flash chromatographic purification which resulted
in bislactone 19 (Scheme 2).
Thus, crude alcohol was directly subjected to Dess–Martin
oxidation conditions to yield ketone 16 along with 17. Mildly
acidic removal of the acetonide moiety in 16 finalized the syn-
thesis of 9-epi carolacton 3. 1H- and 13C-NMR-spectra of 9-epi
carolacton 3 and carolacton 1 diﬀered from each other
especially in the coupling pattern of the protons located
within the lactone ring (see ESI†).
Scheme 2 Synthesis of 9-epi carolacton 3, bislactone 4 and methyl
ester 20 (hydrolysis product 21 is discussed below). Reagents and con-
ditions: a. i. TESOTf, lutidine, CH2Cl2, 0 °C to rt, 12 h; ii. TBAF, 10 min;
b. DDQ, CH2Cl2, pH = 7 phosphate buﬀer, 0 °C to rt, 1.5 h; c. Dess–
Martin periodinane, CH2Cl2, NaHCO3, rt, 2 h (16: 7% for three steps; 17:
13% for three steps); d. PPTS, i-PrOH/H2O (3 : 1), 8 d, 68 °C (22%);
e. PPTS, MeOH, rt, 16 h (4: 60%; 20: 35%); (TESOTf = triethylsilyl triﬂuoro-
methane-sulfonate, TBAF = tetra-n-butylammonium ﬂuoride).
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In addition, we removed the acetonide protection at C17/
C18 in bislactone 19 and obtained the two carolacton deriva-
tives 4 and triol 20. The latter is formed by transacylation of
the δ-lactone moiety in 19 with the solvent MeOH.
The synthesis of bislactone 7 was reported before18 and was
achieved by acyl chloride formation of carolacton 1 and regio-
selective macrolactonization (p-Br-C6H4-COCl, Et3N, 4-DMAP,
CH2Cl2, −10 °C, 2.5 h; 71%). 17-Dehydro carolacton 6 was
obtained by selective oxidation at C17 using the reagent
system 4-acetamido-TEMPO in the presence of the other sec-
ondary carbinol at C18.28,29
Biological activity of carolacton analogues
To quantitatively compare the activity of carolacton with that
of the new synthetic derivatives, live/dead staining of S. mutans
biofilms was used as a sensitive read-out (Fig. 2A). Both,
natural carolacton as well as synthetically obtained carolacton
125 showed the same activity of approximately 60% biofilm
damage even at a concentration as low as 0.05 µM. These
results further confirm that the total synthesis had provided a
compound identical to natural carolacton (data not shown).
Carolacton derivatives 2–4 and 6 had no eﬀect on biofilm via-
bility of S. mutans. Especially the results for two derivatives are
noteworthy. The only diﬀerence between derivative 3 and caro-
lacton is an inverted stereogenic center at C9 and this small
change had a dramatic eﬀect on the biological activity. The
loss of activity observed for derivative 6 is also noteworthy,
because structurally it diﬀers from the biologically active
methyl ester 5 only in the oxidation state at C17 which implies
that the (R)-configured carbinol moiety at C17 is crucial.
Derivatives 5 and 7 had a similar activity as carolacton and
were studied in more detail (Fig. 2B). Methyl ester 5 showed a
concentration dependent loss in activity as observed pre-
viously.21 It was not active any more at a concentration of
0.1 µM. Likewise, bislactone 7 also did not show biofilm
inhibitory activity at a concentration of 0.05 µM. These results
can be interpreted in two ways: (a) either the carolacton deriva-
tives have a lower activity due to diﬀerences in their interaction
with the molecular target of carolacton, or (b) a small amount
of native carolacton 1 is formed by enzymatic or spontaneous
hydrolysis of the ester group in derivatives 5 and 7, respect-
ively, which is responsible for the inhibitory eﬀect.
Reextraction of carolacton and its derivatives after incubation
in media and biofilm cultures
Since carolacton 1 damages S. mutans biofilms at nanomolar
concentrations, we next had to clarify the origin of activity
found for methyl ester 5 and bislactone 7, respectively. First,
we tested the chemical stability of the semisynthetic deriva-
tives 5 and 7 in DMSO, the solvent of choice in our assay
system. We encountered no formation of carolacton 1 over a
period of several days as judged by RP-HPLC-MS (data not
shown). Next, we investigated whether derivatives 5 and 7 are
hydrolyzed in the medium used for cultivating biofilms, or if
enzymatic activity for hydrolyzing the ester groups is present
in the bacterial cultures. This was studied by carrying out re-
extraction (a) from biofilms, (b) from the supernatants after
20 h of cultivation with S. mutans and (c) from the sterile
medium after 20 h of incubation in the absence of bacteria.
The results are shown in Fig. 3.
The EIC (extracted ion chromatogram) obtained from
RP-HPLC analysis showed traces of carolacton 1 (blue curve) in
the supernatant of the biofilm that had been treated with
methyl ester 5 (orange curve) and bislactone 7 (orange curve)
respectively. Carolacton was also detected when biofilms
exposed to derivative 7 were re-extracted. The UV spectrum
(200–600 nm) is shown in black and the base peak chromato-
gram is presented in pink for all samples analyzed. The reten-
tion time of carolacton 1 determined by UV spectroscopy was
in the range of 12.12–12.30 min. The EIC of methyl ester 5
(supernatant) and bislactone 7 (supernatant as well as biofilm)
showed signals that correspond to carolacton 1. The corres-
ponding EIC that was taken from biofilms treated with bislac-
tone 7 showed a very small signal of carolacton 1. Additionally,
the presence of carolacton 1 was further confirmed by mass
spectrometry (see ESI†). The concentration of carolacton in the
supernatants was quantified by integrating the peak area of
the EIC and comparing it with signals from 5 and 7, respect-
Fig. 2 Inhibition of the viability of bioﬁlm cells by carolacton and syn-
thetic derivatives. (A) Incubation of S. mutans bioﬁlms with 5.3 µM caro-
lacton 1 or the synthetic compounds 2–7 for 24 h. (B) Bioﬁlms of S.
mutans were incubated with natural carolacton or the synthetic com-
pounds 5 and 7 at the indicated concentrations for 20 h.
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ively. These determinations showed that carolacton rep-
resented 7.0% of 5 and 20.7% of 7. This corresponds to a con-
centration of 0.35 µM and 1.03 µM carolacton 1, respectively.
HRMS analysis showed two m/z signals of 469.27 [M + H+] and
491.26 [M + Na+] that correspond to carolacton 1 (see ESI†). In
contrast, no formation of carolacton was detected in the sterile
cultivation medium incubated for 20 h in the absence of bac-
teria. While native carolacton could be re-extracted from the
supernatants of biofilms treated with methyl ester 5, we were
not able to re-extract it from the biofilm itself (data not
shown), most likely because the concentrations were too low.
From these results, it can be concluded that the pro-
nounced biological eﬀect of carolacton derivatives 5 and 7 is
very likely due to ester hydrolysis and generation of carolacton
1 under the assay conditions. Since both derivatives remained
intact in the sterile cultivation medium, the data strongly
suggest that the hydrolysis is caused by microbial enzymes.
This assumption was further supported when comparing
the activities determined for the two ester derivatives 5 and 7,
with the amount of carolacton that could be re-extracted after
biofilm incubation. A starting concentration of 1 µM for the
methyl ester 5 yielded about 70 nM of carolacton 1 after hydro-
lytic cleavage, which corresponds to the transformation of
about 7%. This amount resulted in almost maximum biofilm
damage. At a concentration of 0.1 µM of derivative 5, which
corresponds to 7 nM carolacton 1, no biofilm damage was
observed, in accordance with the lowest detectable activity at
10 nM determined previously.19 The bislactone 7 yielded about
21% of carolacton at a concentration of 0.1 µM. This corres-
ponds to 21 nM carolacton which resulted in about half-
maximum biofilm damage as expected.19 From these results
we conclude that the higher activity of bislactone 7 compared
to methyl ester 5 is caused by the larger fraction of carolacton
1 that is formed from the former derivative by biological
hydrolysis.
Likewise, we studied the chemical stability of the two ester
derivatives 4 and 6 under the assay conditions by analyzing
samples after reextraction from (a) biofilms, (b) the super-
natants after 20 h of cultivation with S. mutans and (c) the
sterile medium after 20 h of incubation. If ester hydrolysis
occurs for those compounds as well, this would prove that the
corresponding free acids are inactive like the parent com-
pounds 4 and 6. UPLC-ESI-MS and MS/MS analyses of extracts
from cultures incubated with lactone 4 indeed revealed the
presence of the starting material 4 along with the hydrolysis
product 21 (see Scheme 2). The degree of hydrolysis was esti-
mated by integration of the ion chromatograms (sodium
adducts of carboxylic acid 21 and lactone 4) and 20% were
found in the biofilm sample (a), 7% in the supernatant (b)
and 40% in the sterile medium (c). The identity of the car-
boxylic acid 21 was verified by high resolution MS and MS-MS-
experiments. From these results we conclude that neither the
δ-lactone 4 nor the corresponding free acid 21 exert inhibitory
activity towards biofilms of S. mutans and consequently the
keto group at position 5 in carolacton 1 is biologically essen-
tial. Extracts collected from biofilms incubated with ketone 6
were diﬃcult to analyze, most likely due to the highly reactive
enone moiety. Indeed, most of the starting material had
decomposed and only traces of keto derivative 6 were found as
judged by UPLC-MS analysis.
Eﬀect of carolacton on biofilms of S. gordonii, S. oralis and
Aggregatibacter actinomycetemcomitans
Carolacton 1 aﬀects biofilms that are formed by streptococci in
diﬀerent ways. Assessment of biofilm morphology and viability
Fig. 3 Detection of carolacton and synthetic derivatives by
RP-HPLC-MS analysis in bioﬁlm cells and bioﬁlm supernatants of Strep-
tococcus mutans after 20 h of incubation. Panel A shows the RP-HPLC
proﬁles of the pure compounds. The UV chromatogram (black) is shown
for all samples in all the panels. The EIC is shown for pure carolacton 1
[blue; mass (M) = 468.58], 5 [green; mass (M) = 482.28 ] and 7 [pink;
mass (M) = 450.26)]. Panels B, C and D show the RP-HPLC analysis for
extracts from S. mutans bioﬁlms treated with 5 (supernatant), 7 (super-
natant) and 7 (bioﬁlm) respectively, with the UV and the base peak chro-
matogram (BPC; Pink). The corresponding mass spectra can be found in
the ESI.†
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by confocal laser scanning microscopy (CLSM) after 24 h of
culturing uncovered a reduction of viable cells within
S. mutans biofilms as described previously. This was indicated
by an increased PI uptake that resulted in predominantly red-
fluorescent bacterial cells (Fig. 4C). CLSM images of S. gordonii
and S. oralis biofilms mainly showed green fluorescent bac-
teria, indicating that no membrane damage was induced by
carolacton treatment (Fig. 4B and D). However, the mor-
phology of carolacton treated biofilms showed large diﬀer-
ences to untreated biofilms. For S. gordonii, a more
voluminous structure could be observed, with predominantly
vertically orientated cell chains, while the control biofilms dis-
played more tightly packed biofilm architecture (Fig. 4B). For
S. oralis, the CLSM analyses revealed massively reduced
biofilm formation in the presence of carolacton 1. Thus, the
cell density on the substratum surface was considerably
reduced. A. actinomycetemcomitans biofilms showed no mem-
brane damage as judged by CLSM. A small change in bacterial
cell morphology was observed: in the presence of carolacton 1,
the rod-like A. actinomycetemcomitans cells appeared to be
extended (Fig. 4A). The data confirmed these results and
showed that indeed carolacton had only a very weak eﬀect on
the membrane damage of S. gordonii and S. oralis biofilms,
which was moreover strongly dependent on the density of the
inoculum culture and the age of the biofilm (see ESI†).
However, carolacton inhibited growth of S. oralis biofilms (see
ESI†). To determine if the observed changes in biofilm mor-
phology might be caused by a diﬀerent growth behavior of the
cells, carolacton treated streptococci were inspected under the
fluorescence microscope (see ESI, Fig. S6†). All streptococci
showed elongated cell chains. This had been observed for
S. mutans before19 and was most striking for S. gordonii cul-
tures. These cell chains might be the reason for the volumi-
nous biofilms of S. gordonii treated with carolacton. S. oralis
cultures also formed elongated cells when treated with carolac-
ton, although to a lesser extent. The data confirm that the
primary eﬀect of carolacton is a defect in cell wall synthesis
and cell division. The strong membrane damage observed in
S. mutans biofilms is a secondary eﬀect caused by the acidifica-
tion of the environment during biofilm growth and is elimi-
nated in a buﬀered medium as described.21
Localized release
Because of the activity of carolacton 1 against oral microorgan-
isms, including the caries pathogen S. mutans, it might be
possible to prevent biofilm formation locally. Carolacton was
therefore included in dental filling material, and the viability
of S. mutans biofilms grown on this material was shown to be
reduced. The small amounts of carolacton needed did not
impact the mechanical properties of the material.22 Here, we
found another possibility to control the release of carolacton
to the microorganisms:
Remarkably, ester derivatives 5 and 7 that lack the free carb-
oxylate group still show biofilm inhibitory activity in a similar
range as carolacton 1. As demonstrated in this report for
bislactone 7 and methylester 5 the activity is due to hydrolysis
of the lactone ring attached to C-18 by bacterial enzymes and
in both cases carolacton 1 is formed. δ-Lactone derivative 4
and methyl ester 6 also hydrolyze under the assay conditions
but neither the parent compounds nor the hydrolysis products
exerted biofilm inhibitory activity. In the former case this is
due to the lack of the essential keto group at C5. In the latter
case 17-dehydro carolacton would be the hydrolysis product.
As a result of these studies derivatives 5 and 7 can be
viewed as prodrugs that are activated by S. mutans through
enzymes that hydrolyze the ester at C-1. Consequently, the
microorganisms initiate their own death. It is noteworthy that
similar strategies have been applied rationally30 in biomedical
applications. For example, polymeric dental surfaces have
been activated by triggering the release of bioactive com-
pounds or drugs using enzymes.31
Experimental procedures
The biological test procedures and NMR spectroscopic data
as well as signal assignments of all intermediates and final
Fig. 4 Inﬂuence of carolacton on bioﬁlm morphology and viability.
Bioﬁlm analysis by CLSM after 24 h incubation with and without carolac-
ton: (A) Aggregatibacter actinomycetemcomitans; (B–D) 3D recon-
structed images of (B) Streptococcus gordonii, (C) S. mutans and (D) S.
oralis.
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products are listed in the ESI.† Carolacton derivative 5 was
reported before.21 The synthesis of advanced intermediates 8
and 9 and derivatives 11a,b and 12 are described in ref. 22 and
carolacton derivative 6 in ref. 28. Ligand 10 was prepared
according to Kishi et al.32 Carolacton derivative 7 was first
reported by Jansen et al.18 The biological test procedures are
described in detail in the ESI.†
Preparation of ketone 12
To a solution of an epimeric mixture of alcohols 11a/11b
(100 mg, 139 μmol, 1 equiv.) in CH2Cl2 (4 mL) a mixture of
Dess–Martin periodinane (100 mg, 0.24 mmol, 1.7 equiv.) and
NaHCO3 (100 mg, 1.18 mmol, 8.5 equiv.) were added under air
at 0 °C. The reaction mixture was warmed to rt and stirred for
1 h. After addition of an aqueous, saturated Na2S2O3-solution
the resulting mixture was stirred vigorously for 40 min. The
layers were separated and the aqueous layer was extracted four
times with CH2Cl2. The combined, organic layers were dried
over MgSO4 and concentrated under reduced pressure. Purifi-
cation by flash chromatography (petroleum ether : ethyl
acetate = 4 : 1) provided ketone 12 (89 mg, 124 μmol, 89%) as
a colorless oil. [α]25D = −15.1° (c = 0.65, CH2Cl2); Rf = 0.33
(petroleum ether : ethyl acetate = 3 : 1); HRMS (ESI): m/z for
C41H64O10Na [M + Na]
+: calculated 739.4397, found 739.4377.
Lactonization of epimeric alcohols 13a and 13b
Route A: to a solution of alcohol (S)-11a (53 mg, 75 μmol,
1 equiv.) in THF (3 ml) an aqueous solution of 1 M LiOH
(0.27 mL) and water (0.3 mL) were added at rt. The solution
was stirred for 15 h and aqueous 1 M HCl (0.36 mL) was
added. After addition of saturated, aqueous NH4Cl and ethyl
acetate the layers were separated. The aqueous layer was
extracted three times with ethyl acetate. The combined,
organic layers were washed with brine, dried over MgSO4 and
concentrated under reduced pressure. Seco acid 9-(S)-13a was
obtained as a colorless oil and was used for the next step
without further purification (53 mg, quant). Rf = 0.30 (CH2Cl2 :
MeOH = 20 : 1).
To a solution of triphenylphosphine (305 mg, 1.17 mmol,
15 equiv.) in THF (20 mL) was added diisopropyl azodicarboxy-
late (0.23 mL, 1.13 mmol, 15 equiv.) at rt. The solution was
cooled to 0 °C and a solution of the above mentioned seco
acid 9-(S)-13a (53 mg, 75 μmol, 1 equiv.) in THF (20 mL) was
added via syringe pump within 2 h. The reaction mixture was
allowed to warm to rt and stirred for 3 h. The reaction mixture
was filtered through a pad of Celite™ and washed with an
aqueous phosphate buﬀer solution (pH 7). Layers were separ-
ated and the aqueous layer was extracted three times with
diethyl ether. The combined organic layers were washed with
brine, dried over MgSO4 and concentrated under reduced
pressure. Purification by flash chromatography (petroleum
ether : ethyl acetate = 8 : 1) provided lactones 15 (19 mg,
28 μmol, 37%; fraction 1) and 9-epi-14 (20 mg, 29 μmol, 39%;
fraction 2) as colorless oils in 76% total yield (dr = 1 : 1).
Route B: following the experimental procedure described
above using alcohol (R)-11b (47 mg, 67 μmol, 1 equiv.) as start-
ing material instead provided lactones 15 (30 mg, 44 μmol,
66%; fraction 1) and 14 (15 mg, 29 μmol, 21%; fraction 2) as
colorless oils in 87% total yield (dr = 3 : 1). 14: [α]19D = +1.0° (c =
2.0, CH2Cl2); Rf = 0.27 (petroleum ether : ethyl acetate = 5 : 1);
HRMS (ESI): m/z for C40H63O9 [M + H]
+: calculated 687.4472,
found 687.4476; 15: [α]19D = −17.9° (c = 0.34, CH2Cl2); Rf = 0.28
(petroleum ether : ethyl acetate = 5 : 1); HRMS (ESI): m/z for
C40H63O9 [M + H]
+: calculated 687.4472, found 687.4476.
Synthesis of carolacton derivative 2
To a mixture of lactone 15 (16.4 mg, 24 μmol, 1 equiv.) in
CH2Cl2 (2.5 mL) and aqueous phosphate pH7 buﬀer solution
(0.3 mL, 10 wt%) a solution of 2,3-dichloro-5,6-dicyano-1,4-
benzoquinone (10 mg, 47 μmol, 2 equiv.) in CH2Cl2 (1 mL) was
added within 1 min at 0 °C. The solution was stirred for 4 h.
After addition of an aqueous sodium bicarbonate solution
sodium sulfite (∼100 mg) was added and the resulting yellow
solution was stirred for 10 min. Layers were separated and the
aqueous layer was extracted three times with ethyl acetate. The
combined organic layers were washed with brine, dried over
MgSO4, filtered and concentrated under reduced pressure.
After column chromatography (petroleum ether : ethyl acetate
= 10 : 1 → 5 : 1) alcohol S1 was obtained as a colorless oil
(12.9 mg, 23 μmol, 95%). Alcohol S1: [α]25D = −5.8° (c = 1.2,
CH2Cl2); Rf = 0.14 (petroleum ether : ethyl acetate = 5 : 1);
HRMS (ESI): m/z for C32H54O8Na [M + Na]
+: calculated
589.3716, found 589.3712.
To a mixture of alcohol S1 (12.9 mg, 23 μmol, 1 equiv.) in
CH2Cl2 (5 mL) a mixture of Dess–Martin periodinane (150 mg,
0.35 mmol, 16 equiv.) and NaHCO3 (100 mg, 1.2 mmol,
50 equiv.) was added at 0 °C. The reaction mixture was allowed
to warm to rt and stirred for 24 h. Then, an aqueous, saturated
Na2S2O3-solution was added. The mixture was vigorously
stirred for 1 h. Layers were separated and the aqueous layer
was extracted three times with dichloromethane. The com-
bined, organic layers were dried over MgSO4, filtered and con-
centrated under reduced pressure. Purification by flash
chromatography (petroleum ether : ethyl acetate = 5 : 1) pro-
vided ketone S2 as a colorless oil (7.9 mg, 14 μmol, 62%).
Ketone S2: [α]27D = −55.5° (c = 0.75, CH2Cl2); Rf = 0.26 (pet-
roleum ether : ethyl acetate = 5 : 1); HRMS (ESI): m/z for
C32H52O8Na [M + Na]
+: calculated 587.3560, found 587.3569.
To a solution of ketone S2 (5.0 mg, 9 μmol, 1 equiv.) in
degassed (4 fpt cycles) methanol (2.0 mL) PPTS (2 mg, 8 μmol,
1 equiv.) was added at rt under argon atmosphere. After the
solution was stirred at 60 °C for 22 h water was added
(0.5 mL). A stream of nitrogen was passed over the solution
until the volume had concentrated to a half (∼1 mL). The
remaining solution was directly subjected to HPLC purification
(C18 isis; run time 60 min; ratio H2O :MeOH = 45 : 55 for
5 min then 45 : 55 → 0 : 100 in 45 min; 2 tr = 34.2 min). Diol 2
was obtained as a colourless solid (4.5 mg, 9 μmol, 97%). Caro-
lacton derivative 2: [α]25D = −24.3° (c = 0.21, CH2Cl2); Rf = 0.16
(petroleum ether : ethyl acetate = 2 : 1); HRMS (ESI): m/z for
C29H48O8Na [M + Na]
+: calculated 547.3247, found 547.3248.
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Synthesis of ketone 16 and byproduct 17
To a solution of lactone 14 (29.5 mg, 43 μmol, 1 equiv.) in
CH2Cl2 (3 mL) was added 2,6-lutidine (0.1 mL, 0.9 mmol,
20 equiv.) and triethylsilyl trifluoromethanesulfonate (0.1 mL,
0.43 mmol, 10 equiv.) at 0 °C. The solution was allowed to
warm to rt and stirred for another 16 h. Then, the solution was
recooled to 0 °C and an aqueous, saturated ammonium chlor-
ide solution was added. Layers were separated and the
aqueous layer was extracted three times with ethyl acetate. The
combined, organic layers were washed with brine, dried over
MgSO4, filtered and the solvent was removed under reduced
pressure. The crude product was dissolved in CH2Cl2 (10 mL)
and a mixture of TBAF (60 mg, 0.2 mmol, 4 equiv.) in CH2Cl2
(5 mL) was added at 0 °C. After the solution had been stirred
for 1 h at 0 °C an aqueous, saturated ammonium chloride
solution was added. Layers were separated and the aqueous
layer was extracted three times with ethyl acetate. The com-
bined, organic layers were washed with brine, dried over
MgSO4, filtered and the solvent was removed under reduced
pressure. Purification by flash chromatography (CH2Cl2 :
MeOH = 30 : 1) provided an inseparable mixture of carboxylic
acid S3 and tetrabutylammonium impurities (23.2 mg); Rf =
0.16 (CH2Cl2 : MeOH = 30 : 1).
The above mentioned crude product (S3: approx. 15.5 mg
as judged by 1H-NMR, 25 μmol, 1 equiv.) in CH2Cl2 (2 mL) was
taken up in an aqueous phosphate pH7 buﬀer solution
(0.3 mL, 10 wt%) and a solution of 2,3-dichloro-5,6-dicyano-
1,4-benzoquinone (11.6 mg, 50 μmol, 2 equiv.) in CH2Cl2
(1.5 mL) was added within 1 min at 0 °C. The solution was
stirred for 1.5 h. The completion of the reaction was monitored
by TLC (Rf = 0.33 → 0.20; CH2Cl2 : MeOH = 20 : 1). After
addition of a saturated, aqueous NaHCO3-solution (3 mL)
layers were separated and the aqueous layer was extracted five
times with ethyl acetate. The combined, organic layers were
washed with brine, dried over MgSO4, filtered and concen-
trated under reduced pressure. The dark red residue (hydroxy-
carboxylate S4) was dissolved in CH2Cl2 (6 mL) and a mixture
of Dess–Martin periodinane (64 mg, 0.15 mmol, 6 equiv.) and
NaHCO3 (34 mg, 0.65 mmol, 16 equiv.) were added at 0 °C.
The reaction mixture was allowed to warm to rt and stirred for
2 h. Then, an aqueous, saturated Na2S2O3-solution was added.
The mixture was vigorously stirred for 20 min. Layers were sep-
arated and the aqueous layer was extracted five times with
ethyl acetate. The combined, organic extracts were washed
with brine, dried over MgSO4 and concentrated under reduced
pressure. In a first purification step by flash chromatography
(CH2Cl2 : MeOH = 20 : 1) bislactone 17 was separated from
ketone 16. Bislactone 17 was purified by a second flash chrom-
atography (petroleum ether : ethyl acetate = 2 : 1) to yield a col-
orless oil (2.8 mg, 5.8 μmol, 13% for 3 steps). Ketone S4 was
purified by HPLC (C18 isis; run time 60 min; ratio H2O : MeOH
= 80 : 20 for 5 min then 80 : 20 → 0 : 100 in 50 min; tr =
50.0 min) and was collected as a colorless oil (1.5 mg, 3 μmol,
7% for 3 steps). Ketone 16: [α]25D = −67.3° (c = 0.15, CH2Cl2);
Rf = 0.14 (petroleum ether : ethyl acetate = 20 : 1); HRMS (ESI):
m/z for C28H44O8Na [M + Na]
+: calculated 531.2934, found
531.2939; 17: [α]20D = −40.0° (c = 0.13, CH2Cl2); Rf = 0.66 (pet-
roleum ether : ethyl acetate = 20 : 1); HRMS (ESI): m/z for
C28H44O7Na [M + Na]
+: calculated 515.2985, found 515.2990.
Synthesis of 9-epi-carolacton 3
To a solution of ketone S4 (1.5 mg, 3 μmol, 1 equiv.) in
degassed (5 fpt cycles) isopropyl alcohol (1.2 mL) and water
(0.4 mL) PPTS (4 mg, 15 μmol, 6 equiv.) was added at rt. The
solution was stirred at 68 °C for 8 days and then cooled to rt.
The reaction mixture was concentrated to half of the original
volume (about 0.8 mL) by passing a stream of nitrogen over
the solution. The remaining material was directly purified by
HPLC (C18 isis; run time 60 min; ratio H2O :MeOH = 20 : 80 →
0 : 100 in 55 min; 9-epi-carolacton 3 tr = 37.8 min and starting
material S4 tr = 46.1 min). This procedure was repeated with
the reisolated starting material S4. The products obtained
from both reactions were combined and 9-epi-carolacton 3 was
obtained as a colorless oil (0.3 mg, 1 μmol, 22%). 9-epi-Carolac-
ton 3: [α]19D = −43.0° (c = 0.03, CH2Cl2); Rf = 0.36 (CH2Cl2 :
MeOH = 10 : 1); HRMS (ESI): m/z for C25H40O8Na [M + Na]
+:
calculated 491.2621, found 491.2618.
Synthesis δ-lactone 4 and methyl ester 20
To a solution of bislactone 19 (1.5 mg, 3 μmol, 1 equiv.) in
degassed (4 fpt cycles) methanol (2.0 mL) PPTS (3 mg,
12 μmol, 4 equiv.) was added at rt. Water was added (50 μL)
after the solution had been stirred at rt for 16 h. The reaction
mixture was concentrated to about half of its original volume
(about 1 mL) by passing a stream of nitrogen over the solution.
The remaining material was directly purified by HPLC (C18
isis; run time 60 min; ratio H2O :MeOH = 45 : 55 for 5 min
then 45 : 55 → 0 : 100 in 45 min; 4 tr = 27.6 min & 20 tr =
30.1 min). Diol 4 was obtained as a colorless solid (0.8 mg,
2 μmol, 60%) and triol 20 as a viscous gel (0.5 mg, 1 μmol,
35%). δ-Lactone 4: [α]20D = −8.8° (c = 0.08, CH2Cl2); Rf = 0.15
(petroleum ether : ethyl acetate = 1 : 1); HRMS (ESI): m/z for
C25H40O7Na [M + Na]
+: calculated 475.2672, found 475.2660;
methyl ester 20: [α]20D = −40.0° (c = 0.05, CH2Cl2); Rf = 0.21 (pet-
roleum ether : ethyl acetate = 1 : 1); HRMS (ESI): m/z for
C26H44O8Na [M + Na]
+: calculated 507.2943, found 507.2945.
Synthesis of methyl ester 5
To a solution of carolacton 1 (20.9 mg, 44.6 μmol, 1 equiv.) in
CH2Cl2/MeOH (10 : 1, 11 mL) a solution of trimethyl-
silyldiazomethane in hexane (0.15 mL, c = 2 mol L−1,
0.30 mmol, 6.7 equiv.) was added dropwise at rt. Ethyl acetate
(6 drops) was added after the reaction mixture had been
stirred at rt for 1 h. The reaction mixture was concentrated
under reduced pressure and the residue was purified by HPLC
(C18 isis; run time 60 min; ratio H2O :MeOH = 80 : 20 for
5 min then 80 : 20 → 0 : 100 in 50 min; 5 tr = 45 min) to obtain
methyl ester 5 as a colorless oil (17.4 mg, 36.1 μmol, 81%);
methyl ester 5: [α]20D = −171.4° (c = 0.5, CH2Cl2); Rf = 0.57
(CH2Cl2 : MeOH = 10 : 1); HRMS (ESI): m/z for C26H42O8Na
[M + Na]+: calculated 505.2777, found 505.2773.
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Synthesis of ketone 6
To a solution of methyl ester 5 (11.1 mg, 23.0 μmol, 1 equiv.)
in CH2Cl2 (1 mL) 4-acetamido-2,2,6,6-tetramethylpiperidine-1-
oxyl (11.9 mg, 56.0 μmol, 2.4 equiv.) and PTSA (10.6 mg,
57 μmol, 2.5 equiv.) were added at 0 °C. CH2Cl2 (5 mL) and a
saturated NaHCO3-solution were added after the reaction
mixture had been stirred at rt for 9 h. Layers were separated
and the aqueous layer was extracted three times with CH2Cl2.
The combined, organic layers were washed with brine, dried
over MgSO4, filtered and the solvent was removed under
reduced pressure. Purification by flash chromatography (pet-
roleum ether : ethyl acetate = 2 : 1) provided ketone 6 as a
yellow oil which was further purified by HPLC (C18 isis; run
time 60 min; ratio H2O :MeOH = 80 : 20 for 5 min then 80 : 20
→ 0 : 100 in 50 min; 6 tr = 44 min) to obtain ketone 6 as a col-
orless oil (7.0 mg, 14.6 μmol, 63%, dr > 20 : 1); ketone 6: [α]20D =
−159.8° (c = 0.4, CH2Cl2); Rf = 0.52 (petroleum ether : ethyl
acetate = 1 : 1); HRMS (ESI): m/z for C26H40O8Na [M + Na]
+:
calculated 503.2620, found 503.2621.
Conclusions
This investigation reports on new carolacton derivatives
including ring-enlarged ones obtained by total synthesis. In
this context, we studied regio- and stereochemical aspects of
the macrocyclization under Mitsunobu conditions in detail.
Our preliminary structure–activity relationship studies demon-
strates that there is currently no modification that retains the
activity of the molecule, including the methylation of the
carbon side-chain. A small change in the stereochemistry of
C9 is suﬃcient to render the molecule inactive. These data
show that the interaction between carolacton and its unknown
biological target molecule must be highly specific. The data
also confirm that the primary eﬀect of carolacton treatment
is a defect in cell division, the extent of which varies
between species of streptococci, but which is also observed,
albeit weakly, in the gram-negative pathogen A. actino-
mycetemcomitans.
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